Funder
National Institute on Aging
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),General Medicine
Reference50 articles.
1. Gertz MA, Dispenzieri A. Systemic amyloidosis recognition, prognosis, and therapy: a systematic review. JAMA. 2020;324(1):79–89.
2. Merlini G, Dispenzieri A, Sanchorawala V, et al. Systemic immunoglobulin light chain amyloidosis. Nat Rev Dis Primers. 2018;4(1):38.
3. Muchtar E, Gertz MA, Kyle RA, et al. A modern primer on light chain amyloidosis in 592 patients with mass spectrometry-verified typing. Mayo Clin Proc. 2019;94(3):472–83.
4. Varga C, Comenzo RL. High-dose melphalan and stem cell transplantation in systemic AL amyloidosis in the era of novel anti-plasma cell therapy: a comprehensive review. Bone Marrow Transplant. 2019;54(4):508–18.
5. Lu R, Richards T. A focus on Waldenstrom macroglobulinemia and AL amyloidosis. J Adv Pract Oncol. 2022;13(Suppl 4):45–56.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. An Unusually Rapid-Onset Portal Hypertension;The American Journal of Medicine;2023-12